Home › Osteosarcoma › Colorado
Osteosarcoma clinical trials in Colorado
6 studies for Osteosarcoma are looking for participants at sites in Colorado.
Cities in Colorado
Cabozantinib With Ifosfamide in Relapsed/Refractory Sarcomas
- Children's Hospital Colorado, Aurora
RecruitingPhase 1
Ages 5 to 40 · All sexes · Updated Sep 3, 2026 · NCT06156410Losartan + Sunitinib in Treatment of Osteosarcoma
- Children's Hospital Colorado, Aurora
- University of Colorado Hospital, Aurora
RecruitingPhase 1
Ages 10 and older · All sexes · Updated Sep 1, 2026 · NCT03900793Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
- Children's Hospital Colorado, Aurora
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated Aug 25, 2026 · NCT04851119Thoracotomy Versus Thoracoscopic Management of Pulmonary Metastases in Patients With Osteosarcoma
- Children's Hospital Colorado, Aurora
- Rocky Mountain Hospital for Children-Presbyterian Saint Luke's Medical Center, Denver
RecruitingPhase 3
Up to age 50 · All sexes · Updated Aug 25, 2026 · NCT05235165Study of Onivyde With Talazoparib or Temozolomide in Children With Recurrent Solid Tumors and Ewing Sarcoma
- Children's Hospital Colorado, Aurora
RecruitingPhase 1/2
12 Months – 30 Years · All sexes · Updated May 19, 2026 · NCT04901702A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid Tumors
- Children's Hospital of Colorado, Aurora
RecruitingPhase 2
18 Months – 40 Years · All sexes · Updated Aug 12, 2025 · NCT05135975From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.